V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007537 | 330004370 | 1.74 | 69.3 | Palliative (P) | 2016-08-22 | 2016-08-26 | Cetuximab 7 day (>Cycle 2) | N | N | 330011606 | CETUXIMAB |
| 330007538 | 330011751 | 1.61 | 55 | Palliative (P) | 2018-02-14 | 2018-03-22 | Rituximab | N | N | 330011612 | RITUXIMAB |
| 330007539 | 330004371 | null | 51.1 | null | null | 2015-10-22 | CETUXIMAB | null | null | 330011630 | CETUXIMAB |
| 330007540 | 330008384 | null | 93.4 | Neo-adjuvant (N) | 2014-02-23 | 2014-03-03 | ETOPOSIDE + IFOSFAMIDE | N | N | 330011640 | ETOPOSIDE + IFOSFAMIDE |
| 330007541 | 330004374 | 1.79 | 53.6 | Curative (C) | 2017-03-26 | 2017-03-26 | PAM x 2 post-surgery (cycles 3&4) | Y | N | 330011643 | MAP |
| 330007542 | 330010551 | 1.75 | 93 | Palliative (P) | 2015-05-13 | 2015-05-15 | Etoposide + Ifosfamide (5 days) | N | N | 330011643 | ETOPOSIDE + IFOSFAMIDE |
| 330007543 | 330004376 | 1.66 | 65.3 | Palliative (P) | 2017-07-06 | 2017-07-12 | OST Euramos 1 Closed Trial - M | N | N | 330011658 | METHOTREXATE HIGH DOSE |
| 330007544 | 330010552 | 1.79 | 57.2 | Palliative (P) | 2017-11-25 | 2017-11-25 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 330011667 | DOCETAXEL + GEMCITABINE |
| 330007545 | 330004378 | 1.83 | 165 | Palliative (P) | 2013-09-25 | 2013-12-19 | Carboplatin AUC 6 - 10 | N | N | 330011676 | CARBOPLATIN |
| 330007546 | 330008387 | 1.79 | 43.5 | Neo-adjuvant (N) | 2014-12-28 | 2015-01-04 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 330011679 | ETOPOSIDE + IFOSFAMIDE |
| 330007547 | 330004381 | 1.79 | 103 | Palliative (P) | 2014-04-04 | 2014-04-23 | Rituximab (Maintenance) | 02 | N | 330011679 | RITUXIMAB |
| 330007548 | 330004384 | 1.78 | 61.8 | Adjuvant (A) | null | 2016-03-31 | Carboplatin AUC 6 - 10 | 02 | N | 330011689 | CARBOPLATIN |
| 330007549 | 330004385 | 1.75 | 47.2 | Neo-adjuvant (N) | 2015-10-17 | 2015-10-17 | Cetuximab 7 day (>Cycle 2) | null | null | 330011692 | CETUXIMAB |
| 330007550 | 330004386 | 1.6 | 61.8 | Adjuvant (A) | 2013-11-30 | 2013-12-28 | DOCETAXEL + GEMCITABINE | N | N | 330011697 | DOCETAXEL + GEMCITABINE |
| 330007551 | 330004387 | 1.72 | 46.4 | Not known (9) | 2015-08-25 | 2015-09-09 | OST Euramos 1 Closed Trial - AP | Y | N | 330011701 | MAP |
| 330007552 | 330008392 | 1.74 | 104 | Adjuvant (A) | 2016-01-18 | 2016-02-01 | Carboplatin AUC 2 - 5 | N | N | 330011707 | CARBOPLATIN |
| 330007553 | 330008392 | 1.62 | null | Curative (C) | 2013-06-18 | 2013-06-19 | MAP | N | N | 330011707 | MAP |
| 330007554 | 330004389 | null | 112 | Palliative (P) | 2017-10-28 | 2017-11-20 | Carboplatin AUC 2 - 5 | 2 | N | 330011728 | CARBOPLATIN |
| 330007555 | 330008393 | null | 82 | Curative (C) | 2014-09-01 | 2014-09-07 | OST Euramos 1 Closed Trial - M | N | N | 330011730 | METHOTREXATE HIGH DOSE |
| 330007556 | 330004392 | 1.72 | 62.3 | Palliative (P) | 2014-04-03 | 2014-04-12 | Carboplatin AUC 6 - 10 | 02 | N | 330011734 | CARBOPLATIN |
| 330007557 | 330004393 | 1.68 | 62.6 | null | 2014-07-23 | 2014-08-10 | Carboplatin AUC 2 - 5 | 02 | N | 330011745 | CARBOPLATIN |
| 330007558 | 330012805 | null | 75.9 | Palliative (P) | 2016-09-23 | 2016-10-12 | CISPLATIN + FLUOROURACIL | N | N | 330011757 | CISPLATIN + FLUOROURACIL |
| 330007559 | 330008395 | 1.8 | 87.7 | Palliative (P) | 2016-12-08 | 2017-01-17 | DOCETAXEL + GEMCITABINE | N | Y | 330011757 | DOCETAXEL + GEMCITABINE |
| 330007560 | 330004396 | null | 60.3 | Palliative (P) | 2015-07-01 | 2015-10-17 | Rituximab (Maintenance) | N | null | 330011761 | RITUXIMAB |
| 330007561 | 330004396 | 0 | 60 | Curative (C) | 2016-04-13 | 2016-04-24 | ETOPOSIDE + IFOSFAMIDE | 02 | Y | 330011761 | ETOPOSIDE + IFOSFAMIDE |
| 330007562 | 330004396 | null | 42 | Disease modification (D) | 2017-07-09 | 2017-07-30 | PAM x 2 pre-surgery (cycles 1&2) | N | N | 330011761 | MAP |
| 330007563 | 330004398 | 0 | 96.8 | Adjuvant (A) | 2014-03-07 | 2014-03-09 | Rituximab | N | N | 330011767 | RITUXIMAB |
| 330007564 | 330004399 | null | 59 | Neo-adjuvant (N) | 2017-04-17 | 2017-04-17 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 330011768 | RITUXIMAB |
| 330007565 | 330004399 | 1.68 | 37.4 | null | 2016-09-14 | 2016-09-19 | DOCETAXEL + GEMCITABINE | 02 | N | 330011768 | DOCETAXEL + GEMCITABINE |
| 330007566 | 330004400 | 1.82 | 69.4 | Palliative (P) | 2014-02-04 | 2014-07-21 | Carboplatin AUC 2 - 5 | N | N | 330011779 | CARBOPLATIN |
| 330007567 | 330004401 | 0 | null | null | 2016-10-12 | 2016-11-11 | Methotrexate High Dose (3g/m2) | N | null | 330011779 | METHOTREXATE HIGH DOSE |
| 330007568 | 330008399 | 1.68 | 55 | Curative (C) | null | 2016-02-19 | Carboplatin AUC 6 - 10 | N | N | 330011785 | CARBOPLATIN |
| 330007569 | 330004404 | null | 60 | Palliative (P) | 2014-04-22 | 2014-05-13 | Cetuximab 7 day (>Cycle 2) | N | null | 330011786 | CETUXIMAB |
| 330007570 | 330004407 | 1.69 | 63.3 | Curative (C) | null | 2014-12-31 | Etoposide + Ifosfamide (3 days) | Y | N | 330011787 | ETOPOSIDE + IFOSFAMIDE |
| 330007571 | 330004410 | 1.63 | 93.9 | Palliative (P) | null | 2014-10-02 | Etoposide + Ifosfamide (3 days) | null | null | 330011787 | ETOPOSIDE + IFOSFAMIDE |
| 330007572 | 330004412 | 1.8 | 76 | Adjuvant (A) | 2015-05-20 | 2015-08-13 | Carboplatin AUC 6 - 10 | 02 | N | 330011807 | CARBOPLATIN |
| 330007573 | 330004413 | 1.65 | 57 | Palliative (P) | null | 2013-05-16 | Cisplatin +Fluorouracil (3 wk) | N | N | 330011808 | CISPLATIN + FLUOROURACIL |
| 330007574 | 330004413 | 1.72 | null | Palliative (P) | 2016-10-19 | 2017-01-08 | MAP | 02 | N | 330011808 | MAP |
| 330007575 | 330004416 | 1.55 | null | Curative (C) | 2014-04-09 | 2014-05-10 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 330011820 | DOCETAXEL + GEMCITABINE |
| 330007576 | 330004417 | 1.55 | null | Palliative (P) | 2016-08-22 | 2016-08-22 | Etoposide + Ifosfamide (5 days) | N | N | 330011824 | ETOPOSIDE + IFOSFAMIDE |
| 330007577 | 330008407 | 1.63 | 58 | Palliative (P) | 2016-11-17 | 2016-11-23 | PAM x 2 pre-surgery (cycles 1&2) | N | Y | 330011825 | MAP |
| 330007578 | 330008409 | 1.57 | 41 | Palliative (P) | 2016-08-02 | 2016-08-07 | DOCETAXEL + GEMCITABINE | 02 | null | 330011826 | DOCETAXEL + GEMCITABINE |
| 330007579 | 330008409 | null | 91.3 | Curative (C) | 2015-01-21 | 2015-02-16 | OST Euramos 1 Closed Trial - M | N | null | 330011826 | METHOTREXATE HIGH DOSE |
| 330007580 | 330004422 | 1.63 | 51.2 | Curative (C) | 2016-07-19 | 2016-07-23 | MAP | 02 | N | 330011841 | MAP |
| 330007581 | 330004422 | 0 | 91.85 | Curative (C) | 2018-06-23 | 2018-06-23 | Carboplatin AUC 2 - 5 | 02 | N | 330011841 | CARBOPLATIN |
| 330007582 | 330012427 | 1.8 | 97.9 | Curative (C) | 2014-04-23 | 2014-04-24 | MAP | N | N | 330011849 | MAP |
| 330007583 | 330012427 | null | 59 | Curative (C) | null | 2014-11-20 | MAP | null | null | 330011849 | MAP |
| 330007584 | 330004423 | null | 100 | Curative (C) | 2016-08-01 | 2016-08-01 | CISPLATIN + FLUOROURACIL | N | N | 330011856 | CISPLATIN + FLUOROURACIL |
| 330007585 | 330004423 | 1.73 | 53.2 | Curative (C) | 2015-11-20 | 2015-11-24 | CETUXIMAB | N | N | 330011856 | CETUXIMAB |
| 330007586 | 330004423 | 1.84 | 74 | Palliative (P) | 2017-11-26 | 2017-12-09 | CARBOPLATIN | N | N | 330011856 | CARBOPLATIN |